A metabolic reprogramming-related prognostic risk model for clear cell renal cell carcinoma: From construction to preliminary application.

Zhang, Qian; Ding, Lei; Zhou, Tianren; Zhai, Qidi; Ni, Chenbo; Liang, Chao; Li, Jie

Zhang, Qian; Ding, Lei; Zhou, Tianren; Zhai, Qidi; Ni, Chenbo; Liang, Chao; Li, Jie.

Afiliación

Zhang Q; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ding L; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhou T; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhai Q; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ni C; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Liang C; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Li J; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Front Oncol ; 12: 982426, 2022.

Article en En | MEDLINE | ID: mdl-36176391

Palabras clave

clear cell renal cell carcinoma; key gene; metabolic reprogramming; prognostic model; weighted correlation network analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google